Evidence map›Paper›PMID 33385161›Full record

ArticleJournal of breast imaging

A Novel Marker, Based on Ultrasound Tomography, for Monitoring Early Response to Neoadjuvant Chemotherapy.

Neb Duric, Peter Littrup, Mark Sak, Cuiping Li, Di Chen, Olivier Roy, Lisa Bey-Knight, Rachel Brem

Open access · bronzeAbstract read
In one paragraph

Article in Journal of breast imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Ultrasound Tomography.Advances in experimental medicine and biology · 2023
    Article
  5. Current and Future Directions of Breast MRI.Journal of clinical medicine · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Neb DuricDelphinus Medical Technologies, Inc., Novi, MI.ORCID 0000-0001-6388-6863
Peter LittrupDelphinus Medical Technologies, Inc., Novi, MI.
Mark SakDelphinus Medical Technologies, Inc., Novi, MI.
Cuiping LiDelphinus Medical Technologies, Inc., Novi, MI.
Di ChenDelphinus Medical Technologies, Inc., Novi, MI.
Olivier RoyDelphinus Medical Technologies, Inc., Novi, MI.
Lisa Bey-KnightDelphinus Medical Technologies, Inc., Novi, MI.
Rachel BremGeorge Washington University, Department of Radiology, Washington, DC.
Delphinus Medical Technologies (United States) · USWayne State University · USGeorge Washington University · US

Funding

Transitioning the SoftVue Breast Scanner to the clinical marketplaceR44CA165320 · NCI · DELPHINUS MEDICAL TECHNOLOGIES, INC. · PI DURIC, NEBOJSA · 2012 to 2018
$3.8M
NCI NIH HHS R44 CA165320
6 · The paper itself

Abstract

objectiveTo evaluate the combination of tumor volume and sound speed as a potential imaging marker for assessing neoadjuvant chemotherapy (NAC) response.

methodsThis study was carried out under an IRB-approved protocol (written consent required). Fourteen patients undergoing NAC for invasive breast cancer were examined with ultrasound tomography (UST) throughout their treatment. The volume (V) and the volume-averaged sound speed (VASS) of the tumors and their changes were measured for each patient. Time-dependent response curves of V and VASS were constructed individually for each patient and then as averages for the complete versus partial response groups in order to characterize differences between the two groups. Differences in group means were assessed for statistical significance using

resultsOn average, tumor volume and sound speed in the partial response group showed a gradual decline in the first 60 days of treatment, while the complete response group showed a much steeper decline (

conclusionThis study demonstrates the feasibility of using UST to monitor NAC response, warranting future studies to better define the potential of UST for noninvasive, rapid identification of partial versus complete responders in women undergoing NAC.

Indexed as

breast cancermonitoring treatmentneoadjuvant chemotherapysound speedultrasound tomography

Identifiers

PMID33385161
PMCPMC7750888
OpenAlexW3097325149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.